Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes and Established Atherosclerotic Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial
Circulation 2020 Oct 07;[EPub Ahead of Print], F Cosentino, CP Cannon, DZI Cherney, U Masiukiewicz, R Pratley, S Dagogo Jack, R Frederich, B Charbonnel, J Mancuso, WJ Shih, SG Terra, NB Cater, I Gantz, DK McGuireFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.